- | Country :
- Taiwan, Province of China
- | organs : -
- | Specialty : -
Extract
This is an open-label extension study of another study protocol, MCS-2-TWN-a. Subjects who have completed the 12-week treatment and procedures under the protocol MCS-2-TWN-a will be eligible for this study.
Inclusion criteria
- Lower urinary tract symptoms ,benign prostatic hyperplasia